NCT07737821 Improv Comedy to Reduce Anxiety and Improve Mental Well-Being in Young Chinese Adults in Hong Kong
| NCT ID | NCT07737821 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2026-08-31 |
| Primary Completion | 2028-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2026-08-31 with a primary completion date of 2028-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if improv comedy helps reduce anxiety symptoms and improve mental well-being in Chinese young adults in Hong Kong. The main questions it aims to answer are: 1. Does improv comedy reduce anxiety symptoms? 2. Does improv comedy improve mental well-being? Researchers will compare participants who join the improv comedy workshops to participants who are placed on a waiting list to receive the workshops later, to see if improv comedy reduces anxiety and improves mental well-being. Participants will: 1. Attend weekly three-hour improv comedy workshops for 4 consecutive weeks 2. Complete four assessments and brief reflections during or around the workshop sessions 3. Take part in up to two individual interviews (optional)
Eligibility Criteria
Inclusion Criteria: * Ethnic Chinese, fluent in spoken Mandarin and able to read Chinese * Never married and without children * No current or past diagnosis of any mental disorder (e.g. anxiety disorders, depressive disorders, bipolar disorder, psychotic disorders) * Mild to moderate anxiety symptoms (defined as a GAD-7 total score between 5 and 14) * No prior experience of formal performance training in drama * Availability to attend at least 3 out of 4 weekly sessions over the 4-week intervention period upon enrolment Exclusion Criteria: * Unstable or severe chronic physical illness that would contraindicate participation in group activities or light-to-moderate physical movement (e.g., uncontrolled hypertension, severe asthma, acute cardiovascular events within the past 6 months) * Moderately severe to severe depression symptoms (defined as a PHQ-9 total score greater than 14) * Suicidal ideation (defined as a score greater than 0 on item 9 of the PHQ-9) * Potential risky drinking behavior (defined as AUDIT-C total score greater than 4)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07737821 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 29 Years, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07737821 currently recruiting?
Yes, NCT07737821 is actively recruiting participants. Contact the research team at haorui_li@connect.hku.hk for enrollment information.
Where is the NCT07737821 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07737821 clinical trial?
NCT07737821 is sponsored by The University of Hong Kong. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.